Key points are not available for this paper at this time.
Design
Review
No takes yet. Share an insight, caveat, or question.
Metabolic effects may inform agent selection in insulin-resistant hypertension; leaves open whether newer agents improve hard endpoints versus diuretics and beta-blockers.
Prichard et al. (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: